PMC:7102591 / 22942-23174 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7102591","sourcedb":"PMC","sourceid":"7102591","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7102591","text":"ro study based on pharmacokinetic models (PBPK). An oral loading dose of 400 mg twice daily, followed by a maintenance dose of 200 mg given twice daily for 4 days seems to be the best option for the management of SARS-CoV-2 infectio","tracks":[{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T252","span":{"begin":213,"end":221},"obj":"Disease"}],"attributes":[{"id":"A252","pred":"mondo_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"subj":"T252","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T158","span":{"begin":105,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T158","pred":"source","obj":"LitCovid-PD-CLO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-MONDO","color":"#dcec93","default":true},{"id":"LitCovid-PD-CLO","color":"#e293ec"}]}]}}